Companion Diagnostics Market 2018; Grows Incredibly at a CAGR of 15.4% | with Leading Players Abbott, Agilent Technologies, ARUP Laboratories, etc. by 2023

Companion Diagnostics Market Report include on MarketReseacrhFuture.com with exhaustive Study. The report aims to provide an overview of Companion Diagnostics Market Report. The report provides key statistics on the market status. Global Forecast till 2023.

Companion Diagnostics Market – Synopsis

The global companion diagnostics market is expected to grow at a CAGR of 15.4% during forecasted period 2017-2023. Companion Diagnostics is the as a bio-analytical method designed for the assessment of the patient to check whether patient responds to a specific medical treatment or not. Companion diagnostics are used to determine which patients are benefited from a certain type of medication or which therapies are best suited for the patients with certain medical conditions. Companion diagnostics involves tests and devices or tools which provide information about the safe and effective use of the specific therapeutic product.

Get Exclusive Sample Copy of Companion Diagnostic Market `spread across 80 Premium Pages, 10+ and Supported with Full TOC, is Available @ https://www.marketresearchfuture.com/sample_request/3077

It not only provides information about the efficacy of the drugs but also the side effects that are associated with the drug. To control the rising cost of the drug discovery and development for the deadly and chronic diseases, the need for companion diagnostics is increasing; and with the increasing demand for the companion diagnostic tools and techniques, the global market for the companion diagnostics is growing.

Segmentation:

The global companion diagnostics market has been segmented on the basis of technology which comprises of Polymerase chain reaction (PCR), In-situ hybridization, and immunohistochemistry. On the basis of application, market is segmented into cancer, infectious diseases, cardiovascular diseases, CNS diseases, and others. On the basis of end user, market is segmented into pharmaceutical & biotech companies, clinical laboratories, CRO, and other.

Industry Updates:

December, 2016 Agilent Technologies announced the acquisition of Multiplicom N.V., a Leading European Diagnostics Company. The acquisition of Multiplicom significantly strengthens our presence in the genomics market

August, 2016 Abbott announced the introduction of its new “Alinity”, a family of next generation systems across immunoassay, clinical chemistry, point of care, haematology, blood and plasma screening and molecular diagnostics.

Avail Stunning Discount @ https://www.marketresearchfuture.com/check-discount/3077

Top Players:

Qiagen (Germany), Dako (Denmark), f. Hoffmann-la Roche ltd (Switzerland), Ventana Medical Systems, Inc. (US), Abbott Laboratories, Inc. (US), Resonance Health (Australia) and Agilent Technologies (US) are some of the leaders driving the Global Companion Diagnostics Market. Profiling those in its analysis MRFR finds out their strategies placing them at the forefront of completion.

Global Companion diagnostics Market – Regional:

Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa. The North America includes the U.S., and Canada; and presently, they together dominate the global companion diagnostic market. Further, South America comprises of countries such as Brazil, Peru, Columbia, and Panama among others, and they all contribute a very small share in the global companion diagnostic market.

Europe, accounts for the second largest, in the global companion diagnostics market. The European region includes both Western and Eastern European countries which are involved in development of companion diagnostics. The major countries in the Western Europe are Germany, France, UK, Italy, and Spain. These companion diagnostic solutions are increasing the efficiency of the healthcare workforce and systems driven by the increasing adoption of precise diagnostic tools, electronic healthcare records and drugs prescribed particularly for a disease.

Asia-Pacific region is estimated to be the fastest growing market due to continuous developments in developing countries like India and China. These countries are increasingly involved in the research and development of the companion diagnostic tools for the better medical outcomes, educating people regarding awareness, and also for treatment of crucial genetic diseases.On the other hand, there are some concerning factors such as lack of infrastructure with proper amenities for medical diagnosis and treatment, few healthcare workers, physicians, and health practitioners over large population may decelerate the growth of the companion diagnostic market to an extent.

Major TOC of Companion Diagnostic Market Research Report- Global Forecast to 2023:

1 Report Prologue

2 Market Introduction

3 Research Methodology

4 Market Dynamics

5 Market Factor Analysis

6 Global Companion Diagnostics Market, By Technology

7 Global Companion Diagnostics Market, By Application

8 Global Companion Diagnostics Market, By End User

9 Global Companion Diagnostics Market, By Region

10 Competitive Landscape

11 Company Profile

Ask any Queries to Experts about Niche Segments, Requires Regional Data and Top Players @ https://www.marketresearchfuture.com/enquiry/3077

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.